Luye Pharma Group has agreed to buy a subsidiary of Swiss counterpart Acino, becoming the latest Chinese healthcare company to look overseas for expansion.
China Resources Enterprise pays $42 million to buy a majority stake in Pacific Coffee from Chevalier Pacific, earning Chevalier a healthy return on its five-year investment.